Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Author Archives: Jill Wechsler
Government to Launch Academic Detailing Program
Some of the $1.1 billion in funding for Comparative Effectiveness Research (CER) provided by last year’s economic stimulus legislation will be used to support a major doctor education campaign on drugs and medical products and procedures. The Agency for Healthcare Research and Quality (AHRQ) plans to contract this fall with a marketing or advertising company [...]
Pharma Cheers Health Reform Legislation
Image by SEIU International via Flickr
After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly.
Of most importance to pharmaceutical companies, the legislation promises to significantly expand the [...]
Posted in News Tagged Health care, health insurance, Insurance, Medicaid, Medicare, Medicare Part D coverage gap, Prescription drug, United States 3 Comments
Tauzin’s Farewell to PhRMA
Image via Wikipedia
In an emotional farewell address to PhRMA, President Billy Tauzin recapped his five years at the helm of the organization and his efforts to “recapture the value of the PhRMA brand” and to “re-earn the trust of people who had lost faith in us.” “We had to take the target off our backs—to [...]

New FDA Campaign Targets Detailing, Trade Shows